print
Eucreas (Vildagliptin + Metformin) for the treatment of diabetes
- Source agency:
- DMTP
- Date of Submission:
- 17/01/2010
- Date of Printing:
- 05/02/2012
- Technology name:
- Eucreas (Vildagliptin + Metformin)
- Technology - type(s):
- Drug
- Patient indications:
- Treatment of type 2 diabetes mellitus patients who are unable to achieve sufficient glucose control at the maximally tolerated dose of oral metformin alone or metformin + Vildagliptin in separate tablets.